Genetics of Parkinson's disease

被引:124
作者
Nussbaum, RL
Polymeropoulos, MH
机构
[1] Lab. of Genetic Diseases Research, Natl. Hum. Genome Research Institute, Bethesda
关键词
D O I
10.1093/hmg/6.10.1687
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
For the past 40 years, research into Parkinson's disease (PD) has been predominantly the province of epidemiologists interested in pursuing the connection between the disease and environmental factors such as viral infection or neurotoxins, Hereditary influences were actually discounted because of a high monozygotic twin discordance rate found in studies that were later shown to be inadequate and inconclusive, There has recently been a resurgence of interest in investigating hereditary factors in PD when it became more and more apparent that a positive family history was a major risk factor for the disease. Meanwhile, it also became increasingly apparent from neuropathological studies that the common, idiopathic form of Parkinson's disease had, in fact, a pathological correlate, i.e., the existence of Lewy bodies, an eosinophilic cytoplasmic inclusion body, distributed diffusely throughout the substnatia nigra, hypothalamus, hippocampus, autonomic ganglia and olfactory tracts. Although candidate gene approaches to linkage in PD families have not been rewarding, a genome wide scan mapped PD to 4q21-23 in one large family with PD with diffuse Lewy bodies, where a candidate gene, alpha-synuclein, resides, This gene encodes a presynaptic protein of which a peptide fragment is known to be a constituent of Alzheimer's disease plaques, The identification of a missense mutation in the alpha-synuclein gene in four independent PD families suggests that at least some fraction of familial PD with diffuse Lewy bodies is the result of an abnormal protein that interferes with normal protein degradation leading to the development of inclusions and ultimately neuronal cell death. There may be common pathogenetic mechanisms involved in alpha-synuclein mutations in PD and beta-amyloid and presenilin gene mutations in Alzheimer's disease.
引用
收藏
页码:1687 / 1691
页数:5
相关论文
共 71 条
  • [1] BARROSO N, 1993, CLIN CHEM, V39, P667
  • [2] BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5
  • [3] FAMILIAL PARKINSONS-DISEASE - A CLINICAL GENETIC-ANALYSIS
    BONIFATI, V
    FABRIZIO, E
    VANACORE, N
    DEMARI, M
    MECO, G
    [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1995, 22 (04) : 272 - 279
  • [4] Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO
  • [5] 2-P
  • [6] PARKINSONS-DISEASE IN TWINS STUDIED WITH F-18 DOPA AND POSITRON EMISSION TOMOGRAPHY
    BURN, DJ
    MARK, MH
    PLAYFORD, ED
    MARAGANORE, DM
    ZIMMERMAN, TR
    DUVOISIN, RC
    HARDING, AE
    MARSDEN, CD
    BROOKS, DJ
    [J]. NEUROLOGY, 1992, 42 (10) : 1894 - 1900
  • [7] MITOCHONDRIAL RESPIRATORY-CHAIN ACTIVITY IN SKELETAL-MUSCLE FROM PATIENTS WITH PARKINSONS-DISEASE
    CARDELLACH, F
    MARTI, MJ
    FERNANDEZSOLA, J
    MARIN, C
    HOEK, JB
    TOLOSA, E
    URBANOMARQUEZ, A
    [J]. NEUROLOGY, 1993, 43 (11) : 2258 - 2262
  • [8] NO EVIDENCE FOR ASSOCIATION OF FAMILIAL PARKINSONS-DISEASE WITH CAG REPEAT EXPANSION
    CARREROVALENZUELA, R
    LINDBLAD, K
    PAYAMI, H
    JOHNSON, W
    SCHALLING, M
    STENROOS, ES
    SHATTUC, S
    NUTT, J
    BRICE, A
    LITT, M
    [J]. NEUROLOGY, 1995, 45 (09) : 1760 - 1763
  • [9] GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES
    CORDER, EH
    SAUNDERS, AM
    STRITTMATTER, WJ
    SCHMECHEL, DE
    GASKELL, PC
    SMALL, GW
    ROSES, AD
    HAINES, JL
    PERICAKVANCE, MA
    [J]. SCIENCE, 1993, 261 (5123) : 921 - 923
  • [10] CHRONIC PARKINSONISM SECONDARY TO INTRAVENOUS-INJECTION OF MEPERIDINE ANALOGS
    DAVIS, GC
    WILLIAMS, AC
    MARKEY, SP
    EBERT, MH
    CAINE, ED
    REICHERT, CM
    KOPIN, IJ
    [J]. PSYCHIATRY RESEARCH, 1979, 1 (03) : 249 - 254